MedPath

IDELVION

IDELVION

Dormant
DIN Number

02451352

Drug Class

Human

Market Date

Jul 4, 2019

Company
HC

csl behring canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02451352
AIG Number0157770003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD04 COAGULATION FACTOR IX
Product Specifications
Dosage FormPowder For Solution ,  Kit
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP)Active
Strength: 1000 UNIT / VIAL
Monograph: COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.